Quantifying beta cell function in the preclinical stages of type 1 diabetes.
Quantifying beta cell function in the preclinical stages of type 1 diabetes.
复制标题
DOI:
10.1007/s00125-023-06011-5
复制
发表时间:
2023-12
期刊:
影响因子:
8.2
通讯作者:
Dayan, Colin
中科院分区:
文献类型:
--
作者:
Galderisi, Alfonso;Carr, Alice L. J.;Martino, Mariangela;Taylor, Peter;Senior, Peter;Dayan, Colin
关键词:
Clinically symptomatic type 1 diabetes (stage 3 type 1 diabetes) is preceded by a pre-symptomatic phase, characterised by progressive loss of functional beta cell mass after the onset of islet autoimmunity, with (stage 2) or without (stage 1) measurable changes in glucose profile during an OGTT. Identifying metabolic tests that can longitudinally track changes in beta cell function is of pivotal importance to track disease progression and measure the effect of disease-modifying interventions. In this review we describe the metabolic changes that occur in the early pre-symptomatic stages of type 1 diabetes with respect to both insulin secretion and insulin sensitivity, as well as the measurable outcomes that can be derived from the available tests. We also discuss the use of metabolic modelling to identify insulin secretion and sensitivity, and the measurable changes during dynamic tests such as the OGTT. Finally, we review the role of risk indices and minimally invasive measures such as those derived from the use of continuous glucose monitoring. The online version contains a slideset of the figures for download available at 10.1007/s00125-023-06011-5.
登录
查看更多内容
影响因子:
16.2
作者:
Cali AM;Man CD;Cobelli C;Dziura J;Seyal A;Shaw M;Allen K;Chen S;Caprio S
通讯作者:
Caprio S
影响因子:
3.7
作者:
Besser REJ;Ludvigsson J;Hindmarsh PC;Cole TJ
通讯作者:
Cole TJ
影响因子:
7.7
作者:
通讯作者:
--
影响因子:
7.7
作者:
Bergman, RN;Ader, M;Van Citters, G
通讯作者:
Van Citters, G
影响因子:
7.7
作者:
Ferrannini, Ele;Mari, Andrea;Skyler, Jay S.
通讯作者:
Skyler, Jay S.